Investing.com - Nemaura Medical reported on Tuesday second quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Nemaura Medical announced earnings per share of $-0.170 on revenue of $74.03K. Analysts polled by Investing.com anticipated EPS of $-0.170 on revenue of $133.33K.
Nemaura Medical shares are down 64% from the beginning of the year and are trading at $2.240 , down-from-52-week-high.
Nemaura Medical shares gained 0.45% in intra-day trade the report.
Nemaura Medical follows other major Healthcare sector earnings this month
Nemaura Medical's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar